ÂÜÀòÂÒÂ×

Mitch Levinson is an experienced leader in the medical device industry, serving as Chief Strategy Officer and Board Member at Pulse Biosciences, Inc. since January 2015, where innovative tissue treatment technology is developed. Levinson is also the Executive Chair at Sensill Inc., a startup focused on point-of-care diagnostics, and a Board Member at ConnectWell, which provides digital health and wellness content. Previous roles include Board Member at Recros Medica, Inc., and Cerebrotech Medical Systems, where groundbreaking neurological monitoring technology was advanced. Levinson played a critical role as President, CEO, and CSO at Zeltiq Aesthetics, contributing to the commercialization of the CoolSculpting® procedure. Educational qualifications include a BS in Engineering Sciences from UC San Diego and an MS in Computer Systems from the University of Phoenix.